Home/Filings/4/0001209191-22-050309
4//SEC Filing

HENSON HEIDI 4

Accession 0001209191-22-050309

CIK 0001822711other

Filed

Sep 15, 8:00 PM ET

Accepted

Sep 16, 4:12 PM ET

Size

5.7 KB

Accession

0001209191-22-050309

Insider Transaction Report

Form 4
Period: 2022-09-14
HENSON HEIDI
Chief Financial Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2022-09-14+125,000125,000 total
    Exercise: $2.98Exp: 2032-09-14Common Stock (125,000 underlying)
Footnotes (1)
  • [F1]Options vest over two years with 1/2 of the shares subject to such option vesting and becoming exercisable on September 14, 2023, and the remaining 1/2 of the shares subject to such option vesting and becoming exercisable in substantially equal monthly installments on the 14th day of each month thereafter, subject to continued service relationship.

Issuer

PARDES BIOSCIENCES, INC.

CIK 0001822711

Entity typeother

Related Parties

1
  • filerCIK 0001283301

Filing Metadata

Form type
4
Filed
Sep 15, 8:00 PM ET
Accepted
Sep 16, 4:12 PM ET
Size
5.7 KB